Searched for
IPCA LABS NEWS
Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...- Reduce Ipca Labs, target price Rs 1,250: Prabhudas LilladherIpca Labs (IPCA) Q1 EBITDA of Rs 3.9 bn was in line with our estimate. Management guidance of 9% revenue growth (excluding Unichem) was bel...
- Reduce Ipca Laboratories, target price Rs 1150: Prabhudas LilladherIpca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 31697.80 Crore) operating in Pharmac...
- F&O Stock Strategy: How to trade Container Corporation, ICICI Pru, IPCA LabsConsidering the prevailing conditions, three stocks have exhibited promising technical setups, presenting an appealing risk-to-reward ratio...
- Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 crore"The Board approved entering into a definitive Share Purchase Agreement (SPA) for the acquisition of 2,35,01,440 fully paid-up equity share...
- Buy Ipca Laboratories, target price Rs 930: EdelweissIpca Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Sale of services ...
- Buy Ipca Laboratories, target price Rs 1300: Anand RathiIpca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 13572.54 Crore) operating in Pharmac...
- Hold Ipca Laboratories, target price Rs 2240: Emkay GlobalIpca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 25653.30 Crore) operating in Pharmac...
- Buy Ipca Laboratories, target price Rs 2650: Motilal OswalIpca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 26931.95 Crore) operating in Pharmac...
- Buy Ipca Laboratories, target price Rs 2420: Motilal OswalIpca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 25377.19 Crore) operating in Pharmac...
- Glenmark rally totally unjustifiable and illogical: Prabhudas Lilladher‘I really do not think there will be any kind of big benefit out of Fabiflu’
- Cadila, Torrent, Ipca Labs surge as malaria drug found effective against Covid-19Trump touted that generic malaria drug hydroxychloroquine has been used with some success in treating Covid-19.
- Emkay Securities maintains buy on IPCA Lab, target price Rs 1,200Despite the difficult situations, IPCA has navigated challenges by focusing on cost reduction, the brokerage said.
- HSBC maintains buy on Ipca Labs, revises target price to Rs 1,090Buy Ipca Laboratories Ltd. at a price target of Rs 1090.0 .
- Stocks in the news: DHFL, IPCA Labs, Jet Airways, HDFC and Alkem LabsDHFL proposed a 35 per cent haircut to all lenders as part of its resolution plan.
- Ipca Labs Q1 profit at Rs 65 croreTotal income stood at Rs 867.56 crore for the quarter under review.
- Despite warning letter, Ipca Lab still a top return generator: Sarabjit Kour Nangra, Angel BrokingIn a chat with ET Now, Sarabjit Kour Nangra, Angel Broking, says since Ipca was already under import alert, the warning letter now means th...
- Prefer Radico Khaitan, Surya Roshni and Ipca Labs: Mayuresh JoshiUnited Spirits, in our opinion, will focus more on profitability than on volume growth which clearly benefits a stock like Radio Khaitan.
- Exit Ipca Labs; it's the next Wockhardt in making: Dipan MehtaInvestors have to try and manage risks by buying into a basket of midcap pharma stocks, which is what we have been advising over the years,...
- Avoid taking risks in pharma sector: Nitin RahejaWe remain a little circumspect especially of valuations in a lot of the companies in the pharma space.
Load More
